Full text is available at the source.
Transforming obesity: The advancement of multi-receptor drugs
Changing Obesity: Progress in Drugs Targeting Multiple Body Receptors
AI simplified
Abstract
Gut-hormone polyagonists may achieve weight reductions of up to 20%-30%.
- GLP-1-based polyagonists target multiple hormone receptors to promote weight loss.
- These treatments may also improve blood sugar levels and conditions like fatty liver and kidney disease.
- Potential cardiovascular benefits are associated with these new pharmacological interventions.
- This approach offers a non-surgical alternative to bariatric surgery for weight management.
AI simplified